Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

STRENGTHENING CAPACITY IN EPIDEMIC ANALYTICS AND MODELING IN CENTRAL AFRICA

Objectif

Central Africa is vulnerable to recurrent and emerging epidemics such as Ebola, Mpox, malaria, and cholera, yet the region faces a critical shortage of professionals trained in epidemiology, biostatistics, and infectious disease modeling. The Strengthening Capacity in Epidemic Analytics and Modelling in Central Africa (SCEAM-CA) project addresses this challenge by scaling up the Master’s program in Outbreak Analytics and Infectious Disease Modeling launched in 2025 at the One Health Institute for Africa (INOHA), University of Kinshasa, and extending it to other Francophone Central African countries. The program will train early-career experts while also delivering short-term workshops to strengthen the skills of professionals from Ministries of Health, National Public Health Institutes, and research organizations. A fellowship and mentorship scheme, including research stays in partner laboratories, will further support career development and foster both South-South and North-South collaboration. Regional networks such as CANTAM will provide clinical and genomic datasets, which students will use for modeling as part of their thesis projects. To enable advanced training and research, INOHA will be equipped with a high-performance computing laboratory and a bilingual e-learning platform, ensuring access to real-world datasets and collaborative tools.

Champ scientifique (EuroSciVoc)

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-JU-CSA - HORIZON JU Coordination and Support Actions

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) HORIZON-JU-GH-EDCTP3-2025-02-two-stage

Voir tous les projets financés au titre de cet appel

Coordinateur

EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP
Contribution nette de l'UE
€ 1,00
Coût total
Aucune donnée

Participants (8)